FDA 483 - Deerland Enzymes dba Deerland Probiotics and Enzymes Inc. - December 19, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Deerland Enzymes dba Deerland Probiotics and Enzymes Inc. in Kennesaw, GA, a dietary supplement contract manufacturer, received a Form 483 with five observations. The inspection revealed significant issues with master manufacturing records, including a lack of specifications for ingredients, endotoxin testing, and pesticide testing for incoming materials. Additionally, the firm failed to verify the identity of a dietary ingredient, used unsuitable equipment, and had deficiencies in quality control review of monitoring records.
- Inspection Date
- December 19, 2024
- Product Type
- Drugs
ID · 2c1e8bea-12b2-4032-993e-43da3a25ad5a